By Max M. Glatt, MD; David J. Pittman, PhD; Duff G. Gillespie, MA; and Donald R. Hills. Price, not given. Pp 117, with 2 illustrations. Edward Arnold Publishers, Ltd., London, 1967.
This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
This concise volume represents an Anglo American effort to clarify the current situation in Great Britain in regard to a group of "problem drugs." These include (1) cannabis; (2) amphetamines; (3) barbiturates; (4) opiates, synthetic opiates, and cocaine; and (5) hallucinogens. Dr. Glatt is a member of the WHO Expert Advisory Panel on Drug Dependence; Mr. Hills is a Research Assistant on an Alcoholism Addiction Unit at St. Bernard's Hospital, Southall; and the other two authors are Social Scientists from Washington University in St. Louis, Mo.
A brief historical perspective of the drugs and their use in Great Britain sheds light on the controversy that has occurred in this country over the advantages and disadvantages of medical management of addiction. The proponents of changes in our laws have pointed to the "British System" to demonstrate the superiority of medical control over the dispensing of narcotics to addicts. Many American authorities,
Murphv TC. The Drug Scene in Great Britain—"Journey Into Loneliness".. Arch Gen Psychiatry. 1968;19(2):255-256. doi:10.1001/archpsyc.1968.01740080127030